Cytokinetics, Incorporated (CYTK) vs Kymera Therapeutics, Inc. (KYMR)
A side-by-side comparison of Cytokinetics, Incorporated and Kymera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CYTK
Cytokinetics, Incorporated
$61.54HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
KYMR
Kymera Therapeutics, Inc.
$102.11HealthcareDelayed quote: Oct 6, 2026, 10:50 AM EDT
Total return — CYTK vs KYMR
growth of $100 · dividends reinvested · last 6yCYTK +160.0% (+17.3%/yr)KYMR +230.3% (+22.0%/yr)KYMR compounded faster over this window
CYTK KYMR
CYTK vs KYMR: by the numbers
- •KYMR is the larger company ($8.40B vs $7.66B market cap).
- •Both run net losses; KYMR's is the smaller (-285.41% vs -1259.87% net margin).
- •KYMR grew revenue faster over the past five years (10.22% vs 4.19% CAGR).
Metrics side by side
Valuation
| Metric | CYTK | KYMR |
|---|---|---|
| P/S ratio | 107.91 | 80.00 |
| P/B ratio | N/A | 5.57 |
Profitability
| Metric | CYTK | KYMR |
|---|---|---|
| Gross margin | 84.97% | 101.98% |
| Operating margin | -695.44% | -891.33% |
| Net margin | -1259.87% | -285.41% |
| ROE | N/A | -19.85% |
| ROIC | -39.80% | -22.30% |
Growth (annualized)
| Metric | CYTK | KYMR |
|---|---|---|
| Revenue CAGR (5Y) | 4.19% | 10.22% |
| Total return CAGR (5Y) | 11.24% | 12.31% |
Frequently asked
- Which has grown faster, CYTK or KYMR?
- Over the past five years, KYMR grew revenue faster — CYTK at a 4.19% CAGR versus KYMR at 10.22%.
- How have CYTK and KYMR total returns compared?
- Over the past 5 years, CYTK delivered 11.24% and KYMR delivered 12.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cytokinetics ROEKymera Therapeutics ROECytokinetics operating marginKymera Therapeutics operating marginCytokinetics revenue growthKymera Therapeutics revenue growthCytokinetics free cash flowKymera Therapeutics free cash flow
Cytokinetics & Kymera Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.